Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Novartis day

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

A round up from pharma, biotech and healthcare

AstraZeneca AZ

AstraZeneca joins Merck in Brexit stockpiling effort

Says it is increasing stores of medicines by around 20%

- PMLiVE

Vyriad inks immunotherapy alliance with Merck/Pfizer

Genetically engineered virus produces immune response in tumours

- PMLiVE

Huntsworth buys Giant Creative Strategy

New acquisition will expand Huntsworth’s reach

- PMLiVE

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

A round-up from pharma, biotech and healthcare

- PMLiVE

Brexit rebels win vote on European Medicines Agency alignment

EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit

- PMLiVE

NHS England to Vertex: come clean on Orkambi offer

Vertex has offered Orkambi at an almost 90% discount to the NHS, according to BioCentury

Data Visualisation

Last week’s Thirsty Thursday was all about data visualisation and was hosted by Katherine Mantell, Managing Director of Leading Edge – part of the Lucid family of companies.Katherine started the session with...

Lucid Group Communications Limited

The True Potential of Mobile Health Tech

In a recent edition of PME, Dennis O’Brien, Lucid CEO and co-founder, discusses the potential of mobile health in improving patient outcomes – a goal that is at the heart...

Lucid Group Communications Limited

- PMLiVE

Novartis follows Pfizer and freezes US prices this year

And still expects revenues to come in at the high end of expectations for 2018

- PMLiVE

Precision Medicine Group acquires Ethos

The services company will boost PMG's capabilities in complex data interpretation

- PMLiVE

Pfizer enters late-stage haemophilia B gene therapy trial

Race is on to free patients of regular injections

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links